CAS 2470424-39-4

Formula: C20H21N7O

InChI: InChI=1S/C20H21N7O/c1-3-19(28)25-16-8-15(5-4-12(16)2)23-17-9-18(24-14-6-7-14)27-20(26-17)13(10-21)11-22-27/h4-5,8-9,11,14,24H,3,6-7H2,1-2H3,(H,23,26)(H,25,28)

InChI key: YKDZIFFKQUNVHH-UHFFFAOYSA-N

SMILES: CCC(=O)NC1=C(C=CC(=C1)NC2=NC3=C(C=NN3C(=C2)NC4CC4)C#N)C

SGC-CK2-1

CAS: 2470424-39-4

SGC-CK2-1

Formula: C₂₀H₂₁N₇O

Purity: 99%

Molecular weight: 375.43

Ref: 54-BUP21948

SGC-CK2-1

CAS: 2470424-39-4

SGC-CK2-1, a CK2 inhibitor, is a inducer of insulin production and secretion in pancreatic β-cells.

Formula: C₂₀H₂₁N₇O

Purity: 99.41%

Color and Shape: Solid

Molecular weight: 375.427

Ref: TM-T40131

SGC-CK2-1

CAS: 2470424-39-4

Formula: C₂₀H₂₁N₇O

Purity: 99.41%

Color and Shape: Solid

Molecular weight: 375.4270

Ref: IN-DA023OJ1

SGC-CK2-1

CAS: 2470424-39-4

SGC-CK2-1 is a molecule that inhibits the activity of casein kinase 2. Casein kinase 2 has been shown to be a drug target for neurodegenerative diseases, which includes Parkinson's disease and Alzheimer's disease. SGC-CK2-1 has shown efficacy in clinical studies as an anticancer agent, although it is not yet known how this drug works at the molecular level. Further research is needed to determine the effects of SGC-CK2-1 on other types of cancer cells, such as glioma or pancreatic cancer cells.

Formula: C₂₀H₂₁N₇O

Purity: Min. 95%

Molecular weight: 375.43 g/mol

Ref: 3D-VYD42439